Fusion Pharmaceuticals Inc. Financing Cash Flow
Fusion Pharmaceuticals Inc. reported Financing Cash Flow of $64.01 million for the 3-month period ending 2024-03-31, per its 10-Q filed 2024-05-07.
Discontinued › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2024-05-07
- Fusion Pharmaceuticals Inc. net cash provided by (used in) financing activities for the quarter ending 2024-03-31 was $64.01M, a 7.55% increase year-over-year.
- Fusion Pharmaceuticals Inc. net cash provided by (used in) financing activities for the quarter ending 2023-12-31 was $57.85M, a 44064.12% increase year-over-year.
- Fusion Pharmaceuticals Inc. net cash provided by (used in) financing activities for the quarter ending 2023-09-30 was $328.00K, a 98.87% decline year-over-year.
- Fusion Pharmaceuticals Inc. net cash provided by (used in) financing activities for the quarter ending 2023-06-30 was $24.31M, a 143.37% increase year-over-year.
- Fusion Pharmaceuticals Inc. net cash provided by (used in) financing activities for fiscal 2023 was $142.01M, a 248.63% increase from fiscal 2022.
- Fusion Pharmaceuticals Inc. net cash provided by (used in) financing activities for fiscal 2022 was $40.73M, a 11638.62% increase from fiscal 2021.
- Fusion Pharmaceuticals Inc. net cash provided by (used in) financing activities for fiscal 2021 was $347.00K, a 99.87% decline from fiscal 2020.
- Fusion Pharmaceuticals Inc. net cash provided by (used in) financing activities for fiscal 2020 was $265.51M, a 408.76% increase from fiscal 2019.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2024-03-31 | $64.01M 10-Q · filed 2024-05-07 | $121.87M derived: sum of 2 quarters · filed 2024-05-07 | $122.19M derived: sum of 3 quarters · filed 2024-05-07 | $146.50M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-31 | $57.85M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $58.18M derived: sum of 2 quarters · filed 2024-03-20 | $82.49M derived: sum of 3 quarters · filed 2024-03-20 | $142.01M 10-K · filed 2024-03-20 |
| 2023-09-30 | $328.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $24.64M derived: sum of 2 quarters · filed 2023-11-07 | $84.15M 10-Q · filed 2023-11-07 | $84.28M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-06-30 | $24.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $83.82M 10-Q · filed 2023-08-08 | $83.95M derived: sum of 3 quarters · filed 2024-05-07 | $112.86M derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-03-31 | $59.52M 10-Q · filed 2024-05-07 | $59.65M derived: sum of 2 quarters · filed 2024-05-07 | $88.55M derived: sum of 3 quarters · filed 2024-05-07 | $98.54M derived: sum of 4 quarters · filed 2024-05-07 |
| 2022-12-31 | $131.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-20 | $29.04M derived: sum of 2 quarters · filed 2024-03-20 | $39.02M derived: sum of 3 quarters · filed 2024-03-20 | $40.73M 10-K · filed 2024-03-20 |
| 2022-09-30 | $28.91M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $38.89M derived: sum of 2 quarters · filed 2023-11-07 | $40.60M 10-Q · filed 2023-11-07 | $40.55M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $9.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $11.70M 10-Q · filed 2023-08-08 | $11.65M derived: sum of 3 quarters · filed 2023-08-08 | $11.70M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $1.71M 10-Q · filed 2023-05-11 | $1.66M derived: sum of 2 quarters · filed 2023-05-11 | $1.72M derived: sum of 3 quarters · filed 2023-05-11 | $1.93M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$50.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-16 | $7.00K derived: sum of 2 quarters · filed 2023-03-16 | $217.00K derived: sum of 3 quarters · filed 2023-03-16 | $347.00K 10-K · filed 2023-03-16 |
| 2021-09-30 | $57.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | $267.00K derived: sum of 2 quarters · filed 2022-11-08 | $397.00K 10-Q · filed 2022-11-08 | $453.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $210.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $340.00K 10-Q · filed 2022-08-09 | $396.00K derived: sum of 3 quarters · filed 2022-08-09 | -$1.90M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $130.00K 10-Q · filed 2022-05-10 | $186.00K derived: sum of 2 quarters · filed 2022-05-10 | -$2.11M derived: sum of 3 quarters · filed 2022-05-10 | $255.73M derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $56.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-17 | -$2.24M derived: sum of 2 quarters · filed 2022-03-17 | $255.60M derived: sum of 3 quarters · filed 2022-03-17 | $265.51M 10-K · filed 2022-03-17 |
| 2020-09-30 | -$2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $255.54M derived: sum of 2 quarters · filed 2021-11-09 | $265.45M 10-Q · filed 2021-11-09 | $265.45M derived: sum of 4 quarters · filed 2021-11-09 |
| 2020-06-30 | $257.84M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-10 | $267.75M 10-Q · filed 2021-08-10 | $267.75M derived: sum of 3 quarters · filed 2021-08-10 | $267.75M derived: sum of 4 quarters · filed 2021-08-10 |
| 2020-03-31 | $9.91M 10-Q · filed 2021-05-11 | $9.91M derived: sum of 2 quarters · filed 2021-05-11 | $9.91M derived: sum of 3 quarters · filed 2021-05-11 | |
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | $0.00 derived: sum of 2 quarters · filed 2021-03-25 | $52.19M 10-K · filed 2021-03-25 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $52.19M 10-Q · filed 2020-11-10 | ||
| 2019-06-30 | $52.19M 10-Q · filed 2020-08-11 |